Business- Page 66

Angi extends AI leadership as one of the first home services marketplaces available through AI Mode in Google Search DENVER, Nov. 04, 2026 (GLOBE NEWSWIRE) — Angi (formerly Angie’s List) (NASDAQ: ANGI),

Acquisition expected to double Orlando laboratory output; internally developed platform connects digital dentistry workflows and lays groundwork for AI-assisted restoration design ORLANDO, Fla., Nov. 04, 2026 (GLOBE NEWSWIRE) — Standard Dental Labs

OLD GREENWICH, Conn., Nov. 04, 2026 (GLOBE NEWSWIRE) — Star Equity Holdings, Inc. (Nasdaq: STRR and STRRP) (“Star” or the “Company”), a diversified holding company, announced today that it will release its

LAS VEGAS, Nov. 04, 2026 (GLOBE NEWSWIRE) — Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that its new executive management team is exploring and considering strategic

The proposed transaction would value SkinJect® at ~$135 million and include financing at closing to support the SKNJCT-005 NDA-enabling study in Gorlin Syndrome patients PHILADELPHIA, Nov. 04, 2026 (GLOBE NEWSWIRE) — Medicus

All-Cash Acquisition Completed; Company Remains Debt-Free Oblivus Provides On-Demand GPU Cloud Computing for AI Training and Inference and Operates a Proprietary GPU Marketplace Company Plans to Scale Rapidly From Approximately $1.5 Million

New CARTITUDE-4 subgroup analyses provide further insights into durable clinical outcomes with CARVYKTI in earlier-line treatment Updated data to be presented from first-in-human trial of LB2501, an investigational, off-the-shelf in vivo CAR-T

Technology business recognized for specialized talent sourcing and expanded consulting capabilities Facts at a Glance: Kelly Technology + Motion Recruitment, a specialty division of Kelly®, has been recognized by Everest Group for

Company Achieves Important Capital Markets Milestone Following Restoration of SEC Reporting Compliance SAN DIEGO, Nov. 04, 2026 (GLOBE NEWSWIRE) — Royale Energy, Inc. (OTCQB: ROYL) (“Royale” or the “Company”) today announced that

WELLESLEY HILLS, Mass., Nov. 04, 2026 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that it will present